The ear-canal impedance and reflection coefficient were measured in an adult group and in groups of infants of age 1, 3, 6, 12, and 24 months over frequency range 125-10,700 Hz. The development of the external ear canal and middle ear strongly affect input impedance and reflection coefficient responses, and this development is not yet complete at age 24 months. Contributing factors include growth of the area and length of the ear canal, a resonance in the ear-canal walls of younger infants, and a probable influence of growth of the middle-ear cavities. The middle-ear compliance is lower in infants than adults, and the middle-ear resistance is higher. The power transfer into the middle ear of the infant is much less than into that of the adult. Such differences in power transfer directly influence both behavioral and physiological measurements of hearing. The difficulties of interpretation of neonatal tympanograms are shown to be a consequence of ear-canal wall vibration. Impedance and reflectance measurements in the 2-4-kHz range are recommended as a potentially useful clinical tool for circumventing these difficulties.
This is the first report of wideband YR responses in neonates. Data were acquired in a few seconds, but the responses are highly sensitive to whether the probe is fully sealed in the ear canal. A real-time acoustic test of probe fit is proposed to better address the probe seal problem. The YR responses provide information on middle-ear status that varies over the neonatal age range and that is sensitive to the presence or absence of risk factors, ear, and gender differences. Thus, a YR test may have potential for use in neonatal screening tests for hearing loss.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.